Antinuclear Antibodies (ANA)

The single most useful thing to know is what the number doesn't do. The American College of Rheumatology states that only about 11 to 13 percent of people with a positive ANA actually have lupus or any autoimmune or connective tissue disease. By their estimate, up to 15 percent of completely healthy adults test positive, and MedlinePlus notes that positivity climbs with age, especially in women over 65. A low-titer positive in someone who feels fine is, more often than not, just a quirk of an immune system that has seen a few decades.

If the titer is how loud the signal is, the pattern is its shape. As the lab dilutes the sample, the glow settles into a recognizable arrangement inside the nucleus, and that arrangement points toward which antibodies are doing the binding. It's a second, independent clue printed right next to the first.

A pattern is a signpost, not a verdict. Laboratories can read the same slide slightly differently, and a single pattern rarely settles anything by itself. It exists to tell the doctor which door to open next. An ANA screen is frequently ordered alongside p-ANCA, since the two answer different autoimmune questions and an atypical perinuclear pattern can be mistaken for nuclear staining. When a positive ANA sits beside a positive c-ANCA, clinicians weigh both patterns against your symptoms before naming an autoimmune disease.

ANA is rarely a routine screen. MedlinePlus describes it as a test ordered when someone already has symptoms that could point to autoimmune disease: lingering joint pain and stiffness, an unexplained rash, persistent fatigue, muscle aches, or fevers without a clear cause. The trouble is that those symptoms are common and nonspecific, so the test gets cast wide, and the wide net is exactly what pulls in so many incidental positives.

A positive result has a long list of explanations that have nothing to do with lupus:

• other autoimmune conditions such as Sjögren's, scleroderma, rheumatoid arthritis, and autoimmune thyroid disease
• recent or ongoing viral infections
• certain medications, which can cause a drug-induced ANA that fades after the drug is stopped
• pregnancy, ordinary aging, and in a meaningful share of people, no identifiable reason at all

Because so many healthy people carry a low-titer ANA, a borderline positive is a question, not an answer. The report itself can't tell you which bucket you fall into. That is the job of the tests it points toward.

A positive ANA is the beginning of a workup, not the end of one. When the titer is high or symptoms are present, clinicians move from the wide screen to specific antibodies that each map to particular conditions. When joint symptoms point toward rheumatoid arthritis rather than lupus, a clinician will often add an anti-CCP test, the antibody most specific for RA. When a positive ANA travels with a positive anti-Jo-1 antibody, the Johns Hopkins Arthritis Center calls the combination very suggestive of polymyositis. The UNC rheumatology guide lists the usual next steps a doctor considers.

If your symptoms turned out to be thyroid-related rather than rheumatologic, the trail may lead instead toward TSH, since autoimmune thyroid disease is one of the conditions that can nudge an ANA positive.

ANA is the front door of the autoimmune panel, the screen that decides whether the more specific antibody tests get ordered at all. On its own it sorts people into "very unlikely to have lupus" and "needs a closer look," and that second group is where the real diagnostic work happens. The autoimmune panel guide walks through how the pieces fit together, and because a lone positive is so easy to over-read, the guide to flagged values is worth a look before you assume the worst.

One last point that the single result hides: ANA titers can drift. A 1:80 that was 1:320 a year ago tells a different story than a 1:80 climbing from nothing, and titers in established disease don't always track how active that disease is. A repeat test months later, read against the first, often says more than either number alone. Because the screen is built to flag faint signals on purpose, our guide to how trustworthy a lab result is explains why an isolated positive deserves a second look before it deserves worry.